Torrent Pharmaceuticals Ltd - 500420 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 46th Annual General Meeting of the Company held on 23rd July, 201923-07-2019
23-07-2019
TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 46th Annual General Meeting of the Company held on 23rd July, 201923-07-2019
Torrent Pharmaceuticals Ltd - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificate20-07-2019
TORRENT PHARMACEUTICALS LTD. - 500420 - USFDA Classifies Inspection At Dahej Facility As OAI
The Company has received a communication from the USFDA classifying the inspection conducted at its Dahej facility in March, 2019 as Official Action Initiated (OAI). The Company already had submitted its initial response to USFDA and commitments given in response to Form 483 observations have been fulfilled. The Company is sending further updates over receiving of this OAI letter. The Company will be engaging with the regulator and is fully committed in resolving this issue at the earliest. The Company does not believe that this inspection classification will have an impact of disruption of supplies or the revenues from operations of this facility. This is for your information and record.17-07-2019
Torrent Pharmaceuticals Ltd - 500420 - Shareholding for the Period Ended June 30, 2019
Torrent Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here16-07-2019
Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We hereby inform that the Company has scheduled a teleconference with Investors/ Analyst on 23rd July, 2019 at 06:30 P.M. to discuss the financial performance of the Company for the quarter ended 30th June, 201915-07-2019
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of Duplicate Share Certificate12-07-2019
Strong domestic business shot in the arm for Torrent Pharma stock
Turnaround of acquired Unichem biz, improving margins, and large brands to aid earnings11-07-2019
TORRENT PHARMACEUTICALS LTD. - 500420 - Press Release - Glenmark & Torrent Sign Licensing Agreement For Co-Marketing Of Remogliflozin Etabonate In India
We would like to inform that the Company and Glenmark Pharmaceuticals Limited has signed licensing agreement for co-marketing of Remogliflozin Etabonate in India. A Press release, containing the transaction details, which is being submitted to the media is enclosed herewith for your information and record.11-07-2019
Torrent Pharmaceuticals Ltd - 500420 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2019 ,inter alia, to consider and approve We would like to inform that a meeting of the Board of Directors will be held on Tuesday, 23-Jul-19, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on 30-Jun-19.10-07-2019